The BOD of Varian Medical Systems ( VAR ) authorizes the repurchase of an additional 6M shares of common stock between August 15, 2014 and December 31, 2015. The 6M
Varian Medical Systems , Inc. (NYSE: VAR ) Q3 2014 Results Earnings Conference Call July 23, 2014 ..... Co. Presentation Operator Greetings and welcome to the Varian Medical Systems Third Quarter Fiscal Year 2014 Earnings Results Conference
Varian Medical Systems reported third-quarter results that ..... ratings stand. We continue to believe Varian is well-positioned to capitalize on ..... freestanding reimbursement is cut once again. Varian reduced its exposure to freestanding clinics
Varian Medical Systems ( VAR +2.4% ) fiscal Q3 results : Total Revenues: $747.7M (+3 ..... Q4 Guidance : Revenue growth: 7 - 15%; EPS: $1.14 - 1.29. VAR shares are down 3% AH on modest volume. Post your comment!
Varian Medical Systems (NYSE: VAR ): FQ3 EPS of $1.02 misses by $0.07 . Revenue of $747.7M (+3.0% Y/Y) misses by $19.82M . Press Release Post your comment!
The FDA issues 510(k) approval to Varian Medical Systems ' ( VAR -0.9% ) Calypso soft tissue Beacon transponder. The grain of rice-size transponder can be implanted throughout the body
Varian Medical Systems reported second-quarter results that ..... remain intact; we continue to believe Varian is well positioned to capitalize on its ..... RapidPlan are enjoying strong uptake. Varian also appears to be benefiting from the
long-term returns in Varian 's U.S. operations ..... regulatory risk surrounds Varian 's products. The path ..... to overall revenue. Varian is the market leader ..... InfiMed and Calypso. Varian Medical Systems designs, manufactures
Varian Medical Systems reported fairly weak fiscal fourth-quarter ..... remain intact; we continue to believe Varian is well positioned to capitalize on its ..... implications provided additional headwinds to Varian 's North American operations, as gross
Oct 23 (Reuters) - Medical device maker Varian Medical Systems Inc reported lower-than-expected fourth-quarter results as demand for its products fell due to uncertainties related to U.S. healthcare...